• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Euro Surveill. Challenges in diagnosing extrapulmonary tuberculosis in the European Union, 2011

Giuseppe

Emeritus
[Source: Eurosurveillance, full text: (LINK). Abstract, edited.]

Eurosurveillance, Volume 18, Issue 12, 21 March 2013

Euroroundups

Challenges in diagnosing extrapulmonary tuberculosis in the European Union, 2011


I Solovic<SUP>1</SUP>, J Jonsson<SUP>2</SUP>, M Korzeniewska- Koseła<SUP>3</SUP>, D I Chiotan<SUP>4</SUP>, A Pace-Asciak<SUP>5</SUP>, E Slump<SUP>6</SUP>, R Rumetshofer<SUP>7</SUP>, I Abubakar<SUP>8</SUP>, S Kos<SUP>9</SUP>, P Svetina-Sorli<SUP>10</SUP>, W Haas<SUP>11</SUP>, T Bauer<SUP>12</SUP>, A Sandgren<SUP>13</SUP>, M J van der Werf ()<SUP>13</SUP>
  1. Catholic University, Ru?omberok, Slovakia
  2. Swedish Institute for Infectious Disease Control, Stockholm, Sweden
  3. National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland
  4. Romanian National Tuberculosis Programme, Institute of Pneumology Marius Nasta, Bucharest Romania
  5. Infectious Disease Prevention and Control Unit, Health Promotion and Disease Prevention Directorate, Superintendence of Public Health, Ministry of Health, the Elderly and Community Care, Malta
  6. RIVM- Centre Infectious Disease Control, The Netherlands
  7. Tuberkulosestation Karlshaus, Otto Wagner Spital, Vienna, Austria
  8. Research Department of Infection and Population Health, University College London, United Kingdom
  9. Lung Hospital Janov, Mirosov, Czech Republic
  10. University Clinic Golnik, Register for TB, Slovenia
  11. Robert Koch Institute, Berlin, Germany
  12. German Committee against Tuberculosis (DZK), Berlin Germany
  13. European Centre for Disease Prevention and Control, Stockholm, Sweden
<HR>
Citation style for this article: Solovic I, Jonsson J, Korzeniewska- Koseła M, Chiotan DI, Pace-Asciak A, Slump E, Rumetshofer R, Abubakar I, Kos S, Svetina-Sorli P, Haas W, Bauer T, Sandgren A, van der Werf MJ. Challenges in diagnosing extrapulmonary tuberculosis in the European Union, 2011. Euro Surveill. 2013;18(12):pii=20432. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20432
Date of submission: 08 November 2011
<HR>In the European Union (EU) 72,334 tuberculosis (TB) cases were notified in 2011, of which 16,116 (22%) had extrapulmonary tuberculosis (EPTB). The percentage of TB cases with EPTB ranged from 4% to 48% in the reporting countries. This difference might be explained by differences in risk factors for EPTB or challenges in diagnosis. To assess the practices in diagnosis of EPTB we asked European Union/European Economic Area (EU/EEA) countries to participate in a report describing the diagnostic procedures and challenges in diagnosing EPTB. Eleven EU Member States participated and reports showed that in the majority EPTB is diagnosed by a pulmonologist, sometimes in collaboration with the doctor who is specialised in the organ where the symptoms presented. In most countries a medical history and examination is followed by invasive procedures, puncture or biopsy, to collect material for confirmation of the disease (by culture/histology/cytology). Some countries also use the tuberculin skin test or an interferon-gamma-release-assay. A wide variety of radiological tests may be used. Countries that reported challenges in the diagnosis of EPTB reported that EPTB is often not considered because it is a rare disease and most medical professionals will not have experience in diagnosing EPTB. The fact that EPTB can present with a variety of symptoms that may mimic symptoms of other pathologies does pose a further challenge in diagnosis. In addition, obtaining an appropriate sample for confirmation of EPTB was frequently mentioned as a challenge. In summary, diagnosis of EPTB poses challenges due to the diversity of symptoms with which EPTB may present, the low level of suspicion of clinicians, and due to the difficulty in obtaining an adequate sample for confirmation.
- ------
 
Back
Top Bottom